Skip to content

Price / book at other companies

Abbott logo
AbbottABT
3.4×-1.3×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
6.2×-1.0×
Pfizer logo
PfizerPFE
1.8×+0.2×
Merck & Co. logo
Merck & Co.MRK
6.5×+1.8×
Boston Scientific logo
Boston ScientificBSX
3.6×-3.1×
Intuitive Surgical logo
Intuitive SurgicalISRG
9.4×-1.0×

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.4%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+32.0%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$563.77B+47.3%
Enterprise value$597.07B+50.5%
P/E26.8×+9.3×
P/S5.9×+1.6×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio-0.2×

Where this comes from

Calculated from Johnson & Johnson’s reported figures.

Based on the most recent quarter.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's price / book?
Johnson & Johnson (JNJ) reported price / book of 7.3× in Q1 2026.
How has Johnson & Johnson's price / book changed year-over-year?
Johnson & Johnson's price / book increased by 41.7% year-over-year, from 5.1× to 7.3×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.